Axsome Therapeutics
AXSM
172.97
-1.37
-0.79%
Axsome Therapeutics
US · AXSM
#1533 by market cap
Listed 2015
172.97
-1.37
-0.79%
Live - 5344 symbols - heartbeat 10s ago
· 2026-10-08 05:31
Pre-market
174.31
+0.77%
After-hours
172.97
0.00%
Overnight
172.59
-0.22%
- Market cap
- 9.06B
- P/E (TTM)i
- -46.13
- P/Bi
- 108.79
- EPSi
- -3.68
- Div yieldi
- 0.00%
- 52W posi
- 38%
Reader sentiment
Are you bullish or bearish on AXSM?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 6 in the most recent period (2026/Q3).
- Total institutional ownership fell 1.0 percentage points.
Institutional ownership
- Held by institutions
- 88.76% -1.02pp
- Institutions
- 600 -6
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund50.96%
Private Company16.65%
Hedge Fund12.03%
Public Company3.27%
VC/PE Fund2.35%
Government Pension Fund2.20%
Individual/Insider1.06%
Sovereign Wealth Fund0.98%
Insurance Company0.16%
Other10.34%
Top holders as of 2026-04-14
Antecip Capital, L.L.C.
14.02% · 7.34M sh
BlackRock
5.93% · 3.10M sh
Vanguard Capital Management, LLC
4.29% · 2.24M sh
Vanguard Portfolio Management, LLC
3.79% · 1.98M sh
Invesco Ltd.
3.04% · 1.59M sh
FMR
2.94% · 1.54M sh
Geode Capital Management, LLC
1.85% · 967.17K sh
State Street Global Advisors
1.50% · 785.66K sh
Morgan Stanley
1.41% · 736.01K sh
Deep Track Capital, LP
1.34% · 700.00K sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 21 buys · 29 sells
| Name | Role | Stake |
|---|---|---|
| Antecip Capital, L.L.C. | -- | 14.02% |
| Mark Coleman | Independent Director | 0.83% |
| Roger Jeffs | Lead Independent Director | 0.11% |
| Nick Pizzie | Chief Financial Officer | 0.08% |
| Mark Saad | Independent Director | 0.02% |
| Herriot Tabuteau | Chairperson & CEO | 0.01% |
| Susan Mahony | Director | 0.00% |
| Ari Maizel | Executive VP & Head of Commercial | -- |
| Mark Jacobson | COO & Secretary | -- |
| Hunter Murdock | General Counsel | -- |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-02 | Mark Jacobson | COO & Secretary | Derivative Exercise and Sale | -10,000 | $12.95–208.65 |
| 2026-08-05 | Herriot Tabuteau | Chairperson & CEO | Derivative Exercise and Sale | -49,664 | $4.95–213.95 |
| 2026-08-05 | Herriot Tabuteau | Chairperson & CEO | Intent to Sell (Form 144) | -4,660 | $210.13 |
| 2026-08-04 | Herriot Tabuteau | Chairperson & CEO | Intent to Sell (Form 144) | -45,004 | $212.85 |
| 2026-06-30 | Herriot Tabuteau | Chairperson & CEO | Derivative Exercise and Sale | -49,666 | $4.95–240.25 |
| 2026-06-10 | Roger Jeffs | Lead Independent Director | Automatic Disposition | -572 | $246.18–249.12 |
| 2026-06-10 | Roger Jeffs | Lead Independent Director | Intent to Sell (Form 144) | -286 | $249.12 |
| 2026-06-09 | Roger Jeffs | Lead Independent Director | Intent to Sell (Form 144) | -286 | $246.18 |
| 2026-06-09 | Susan Mahony | Director | Derivative Exercise and Sale | -600 | $237.21–246.18 |
| 2026-06-09 | Susan Mahony | Director | Intent to Sell (Form 144) | -300 | $246.18 |
| 2026-06-09 | Mark Coleman | Independent Director | Derivative Exercise and Sale | -643 | $249.00 |
| 2026-06-09 | Mark Coleman | Independent Director | Intent to Sell (Form 144) | -643 | $249.00 |
| 2026-06-08 | Herriot Tabuteau | Chairperson & CEO | Derivative Exercise and Sale | -49,670 | $4.95–241.01 |
| 2026-06-08 | Susan Mahony | Director | Intent to Sell (Form 144) | -300 | $237.21 |
| 2026-06-08 | Nick Pizzie | Chief Financial Officer | Derivative Exercise and Sale | -33,000 | $3.50–240.09 |
| 2026-06-07 | Roger Jeffs | Lead Independent Director | Derivative Exercise and Retained | +1,429 | -- |
| 2026-06-07 | Mark Saad | Independent Director | Derivative Exercise and Retained | +1,429 | -- |
| 2026-06-07 | Susan Mahony | Director | Derivative Exercise and Retained | +829 | -- |
| 2026-06-07 | Mark Coleman | Independent Director | Derivative Exercise and Retained | +786 | -- |
| 2026-06-04 | Roger Jeffs | Lead Independent Director | Other Derivative Acquisition | +1,721 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 05:31:53 · For reference only, not investment advice and not tailored to your situation.